Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for ...

Retrieved on: 2024-04-09 19:05:08

Tags for this article:

Merit Cudkowicz

ALS

Neurodegenerative disease

Exosome

Click the tags to see associated articles and topics

Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for .... View article details on hiswai:

Summary

Lonza and NeuroSense Therapeutics collaborate to utilize extracellular vesicles, specifically neuron-derived exosomes, to develop biomarkers for ALS, aiming to improve neurodegenerative disease treatments with support from Merit Cudkowicz.

Article found on: www.pharmexec.com

View Original Article